The Effect of Metformin on Responses to Chemotherapy and Survival in Stage IV Colorectal Cancer with Diabetes | Zendy

Dong-Jun Lee | Zendy; Bun Kim | Zendy; Jin Ha Lee | Zendy; Su Jung Park | Zendy; Sung Pil Hong | Zendy; Jae Hee Cheon | Zendy; Tae Il Kim | Zendy; Won Ho Kim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Effect of Metformin on Responses to Chemotherapy and Survival in Stage IV Colorectal Cancer with Diabetes

Author(s) -

Dong-Jun Lee,

Bun Kim,

Jin Ha Lee,

Su Jung Park,

Sung Pil Hong,

Jae Hee Cheon,

Tae Il Kim,

Won Ho Kim

Publication year - 2012

Publication title -

korean journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.203

H-Index - 25

eISSN - 2233-6869

pISSN - 1598-9992

DOI - 10.4166/kjg.2012.60.6.355

Subject(s) - medicine , metformin , colorectal cancer , hazard ratio , univariate analysis , diabetes mellitus , chemotherapy , cancer , oncology , stage (stratigraphy) , retrospective cohort study , multivariate analysis , gastroenterology , surgery , confidence interval , endocrinology , insulin , paleontology , biology

Metformin is known to lower the risk of cancer and cancer mortality. However, the effect of metformin in stage IV colorectal cancer (CRC) patients with diabetes mellitus (DM) remains unknown. The aim of this study was to evaluate the effect of metformin on tumor response and survival in stage IV CRC patients with DM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research